Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations and deaths during the COVID-19 pandemic compared to the same period in 2019.

This data blog presents statistics on poisonings from six select substances, namely alcohol, cannabis, methamphetamine, opioids, cocaine and e-cigarette/vaping products. It is the fourth data blog in a series presenting statistics on substance-related poisonings reported by the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP), and features a spotlight on cannabis.

CHIRPP is an injury and poisoning sentinel surveillance system currently operating in the emergency departments of 11 pediatric and ten general hospitals across Canada. It collects patients’ accounts of pre-event injury circumstances (“What happened?”), and clinical information is added to the data collection form by hospital staff. CHIRPP captures a more complete picture of the injury event than hospital administrative or mortality data alone, and also identifies less serious injury cases that do not require hospitalization.

To read the complete article, including all relevant data presented, click here: https://health-infobase.canada.ca/datalab/poisonings-surveillance/cannabis.html?utm_source=CSIMS&utm_medium=Email&utm_campaign=launch_substance_poisonings_spotlight_on_cannabis_January_2022_ENG

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top